Founder, Karaktero Capital (2018-Present)
VP, Corporate Development, Celyad Oncology (2018-2018)
Investor relations, Bayer (2014-2018)
Consultant, Egon Zehnder (2011-2014)
Healthcare Analyst, Macquarie (2008-2011)
Buy-side Equity Analyst, Credit Suisse (2006-2008)
Research Scientist, Novartis (2003-2006)
eureKING
128 rue de la Boétie, 75008 Paris, France
info@eureKING.com
Press Contacts
Nicolas Merigeau
+33 (0)1 44 71 94 98
nmerigeau@newcap.fr
Arthur Rouillé
+33 (0)1 44 71 00 15
arouille@newcap.fr